Cancer Home > Adcetris Dosage

Your healthcare provider will determine your Adcetris dosage based on how much you weigh. However, if you develop serious side effects during treatment, you may have to temporarily stop receiving this drug and restart at a lower amount. Adcetris is given as an intravenous injection every three weeks. It is given by a healthcare provider and usually takes about 30 minutes to administer.

An Introduction to Dosing With Adcetris

The dose of Adcetris™ (brentuximab vedotin) your healthcare provider recommends will vary, based on a number of factors, including:
 
  • Your weight
  • How well you tolerate the medication.
 
As is always the case, do not adjust your dosage unless your healthcare provider specifically tells you to do so.
 

Recommended Adcetris Dosage

The usual recommended dosage of Adcetris for the treatment of lymphoma is 1.8 mg per kg body weight (about 0.82 mg per lb) every three weeks. The dose for people who weigh over 220 lbs should be calculated based on a weight of 220 lbs, as this is the maximum recommended dosage. Treatment will generally continue until 16 doses have been given, as long as the medicine is working and is not causing serious side effects.
 
Your healthcare provider may recommend temporarily stopping the medicine if you experience certain Adcetris side effects, such as peripheral neuropathy (numbness, tingling, or burning in the hands or feet from nerve damage) or low white blood cell counts. Once your side effects improve, you may be restarted on a lower dose of 1.2 mg per kg body weight (about 0.54 mg per lb).
 
Some people may experience a potentially serious reaction, known as an infusion reaction, while receiving their Adcetris dosage. Therefore, you will be closely monitored during the infusion. Your healthcare provider may recommend you take other medicines before receiving your dose to help prevent an infusion reaction from occurring. This premedication may include products such as:
 
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.